GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc covers the month of April 2025, with a specific reporting date of April 11, 2025. The document serves as a transaction notification detailing share acquisitions by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan and dividend reinvestment programs.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively reports on specific share transaction volumes and prices for executive compensation and dividend reinvestment.
| Transaction Type | Date | Price per Share | Total Volume (Shares) |
|---|---|---|---|
| Share Reward Plan (Acquisition) | April 9, 2025 | £12.6153 | 140 |
| Dividend Reinvestment | April 10, 2025 | £13.1269 / £13.0668 | 481 |
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document reflects routine compliance disclosures regarding insider shareholdings rather than operational or financial performance changes.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory disclosure of specific share transactions executed on the London Stock Exchange (XLON).
Key Facts for Investor Verification
- Executive Participation: Multiple senior executives, including CEO Emma Walmsley and CFO Julie Brown, acquired shares under the Share Reward Plan on April 9, 2025.
- Dividend Reinvestment: On April 10, 2025, various PDMRs and PCAs reinvested dividends paid on April 10, 2025, to acquire additional ordinary shares.
- Share Price Movement: The transaction price for the Share Reward Plan acquisition (£12.6153) was lower than the price for dividend reinvestment transactions (£13.1269 and £13.0668) executed the following day.
- Transaction Volume: The largest single transaction volume reported was 1,414 shares acquired by Iain Whyte (PCA of the Company Secretary) via dividend reinvestment.
- Instrument Details: All transactions involved Ordinary Shares of 31 1/2 pence each (ISIN: GB00BN7SWP63).